Search Results - "Kannan, Sadhana"
-
1
Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial
Published in Journal of clinical oncology (10-04-2021)“…We report the clinical outcomes of a randomized trial comparing prophylactic whole-pelvic nodal radiotherapy to prostate-only radiotherapy (PORT) in high-risk…”
Get full text
Journal Article -
2
Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma
Published in PloS one (06-07-2018)“…Technological advancements in treatment planning and delivery have propelled the use of intensity-modulated radiation therapy (IMRT) in head and neck squamous…”
Get full text
Journal Article -
3
Optimal adjuvant therapy in elderly glioblastoma: results from a systematic review and network meta-analysis
Published in Journal of neuro-oncology (2020)“…Background There exists lack of consensus worldwide regarding the most optimal adjuvant therapy regimen in elderly patients with newly-diagnosed glioblastoma…”
Get full text
Journal Article -
4
Late Toxicity After Adjuvant Conventional Radiation Versus Image-Guided Intensity-Modulated Radiotherapy for Cervical Cancer (PARCER): A Randomized Controlled Trial
Published in Journal of clinical oncology (20-11-2021)“…Postoperative Adjuvant Radiation in Cervical Cancer (PARCER), a phase III randomized trial, compared late toxicity after image-guided intensity-modulated…”
Get full text
Journal Article -
5
Hydroxychloroquine in the treatment of coronavirus disease 2019: Rapid updated systematic review and meta‐analysis
Published in Reviews in medical virology (01-03-2022)“…Summary Coronavirus disease 2019 (COVID‐19) caused by the novel severe acute respiratory syndrome coronavirus 2 continues to grow and spread throughout the…”
Get full text
Journal Article -
6
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
Published in Journal of clinical oncology (10-04-2018)“…Purpose Chemoradiation with cisplatin 100 mg/m given once every 3 weeks is the standard of care in locally advanced head and neck squamous cell cancer…”
Get full text
Journal Article -
7
Systematic review and meta-analysis of randomized controlled trials comparing elective neck dissection versus sentinel lymph node biopsy in early-stage clinically node-negative oral and/or oropharyngeal squamous cell carcinoma: Evidence-base for practice and implications for research
Published in Oral oncology (01-01-2022)“…•Management of node-negative neck in early-stage oral cancer has been debatable.•Nearly 20-30% of such patients harbour occult metastases in draining lymph…”
Get full text
Journal Article -
8
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
Published in European journal of nuclear medicine and molecular imaging (01-11-2011)“…Purpose Our objective was to conduct a systematic review and meta-analysis of studies assessing the diagnostic performance of 18 F-fluorodeoxyglucose positron…”
Get full text
Journal Article -
9
Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: A randomized controlled trial
Published in Radiotherapy and oncology (01-09-2012)“…Abstract Purpose To compare three-dimensional conformal radiotherapy (3D-CRT) with intensity modulated radiation therapy (IMRT) in curative-intent irradiation…”
Get full text
Journal Article -
10
Clinical biomarker discovery by SWATH-MS based label-free quantitative proteomics: impact of criteria for identification of differentiators and data normalization method
Published in Journal of translational medicine (31-05-2019)“…SWATH-MS has emerged as the strategy of choice for biomarker discovery due to the proteome coverage achieved in acquisition and provision to re-interrogate the…”
Get full text
Journal Article -
11
A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001)
Published in PloS one (04-02-2022)“…Transplant related toxicity is a major therapeutic challenge. We have previously reported that the toxicity of chemotherapy is largely not directly because of…”
Get full text
Journal Article -
12
Overexpression of Mcl-1L splice variant is associated with poor prognosis and chemoresistance in oral cancers
Published in PloS one (19-11-2014)“…Altered expression of Mcl-1, an anti-apoptotic member of the Bcl-2 family, has been linked to the progression and outcome of a variety of malignancies. We have…”
Get full text
Journal Article -
13
Prognostic and predictive significance of nuclear HIF1α expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumab
Published in British journal of cancer (08-12-2020)“…Background Anti-EGFR-based therapies have limited success in HNSCC patients. Predictive biomarkers are greatly needed to identify the patients likely to be…”
Get full text
Journal Article -
14
Prognostic and predictive roles of cancer stem cell markers in head and neck squamous cell carcinoma patients receiving chemoradiotherapy with or without nimotuzumab
Published in British journal of cancer (01-06-2022)“…Background Anti-EGFR-based therapies have limited success in HNSCC patients. Predictive biomarkers are needed to identify the patients most likely to benefit…”
Get full text
Journal Article -
15
Late toxicity within a Phase III clinical trial of IG-IMRT in cervix cancer (PARCER): Reanalysis with time weighted adverse event reporting (MOSES)
Published in Radiotherapy and oncology (01-12-2022)“…•This post-hoc analysis was performed to report the impact of Image guided intensity modulated radiotherapy (IG-IMRT) and three-dimensional conformal…”
Get full text
Journal Article -
16
Bortezomib and cyclophosphamide based chemo-mobilization in multiple myeloma
Published in International journal of hematology (01-12-2020)“…Hematopoietic stem and progenitor cell (HSPC) mobilization regimens in multiple myeloma typically use filgrastim (GCSF) alone or combination of GCSF with…”
Get full text
Journal Article -
17
Prevention of carcinogen-induced oral cancers by polymeric black tea polyphenols via modulation of EGFR-Akt-mTOR pathway
Published in Scientific reports (25-08-2022)“…The overexpression of Epidermal Growth Factor Receptor (EGFR) and dysregulation of its downstream effector pathways are important molecular hallmarks of oral…”
Get full text
Journal Article -
18
Safety and CSF distribution of high-dose erlotinib and gefitinib in patients of non–small cell lung cancer (NSCLC) with brain metastases
Published in European journal of clinical pharmacology (01-10-2020)“…Purpose Patients of non–small cell lung cancer (NSCLC) with brain metastases have limited treatment options. High-dose erlotinib (HDE) and gefitinib (HDG) have…”
Get full text
Journal Article -
19
SARS-CoV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational study
Published in International journal of infectious diseases (01-05-2022)“…•Cohort study in employees of a cancer center in India with complete follow-up.•Period of study spanning the second wave of SARS-CoV-2 pandemic in India.•Very…”
Get full text
Journal Article -
20
Role of Curcumin in Reducing Toxicities Associated With Mucosal Injury Following Melphalan-Based Conditioning in Autologous Transplant Setting
Published in Cell transplantation (01-04-2022)“…Mucositis is nearly inevitable following high-dose chemotherapy. Several pro-inflammatory cytokines play a role in pathogenesis of mucositis. Curcumin inhibits…”
Get full text
Journal Article